AI in medicine and the CFM resolution in Brazil
Understand CFM Resolution No. 2,454/2026 on artificial intelligence in medicine, medical responsibility, governance, risk and data protection.
CFM artificial intelligence medicine resolution 2025 Brazil
Historical search, final regulation in 2026
The term appears because the regulatory discussion gained momentum in 2025. The final regulatory reference is CFM Resolution No. 2,454/2026, which addresses the use of AI in medicine nationwide.
Medical accountability and clinical communication
AI does not take on diagnosis, prognosis or therapeutic decisions
The regulation reinforces that AI tools can support tasks and analyses, but they do not replace the physician's responsibility for clinical decisions, communication with the patient and review of the output.
Governance before adoption
Risk, data, validation and supervision
Hospitals, clinics and healthtechs need to assess purpose, risk level, data used, validation, logs, human oversight, data protection and the suspension process when the tool fails.
Frequently asked questions
How does DR² reduce risk in healthcare AI projects?
DR² works with human review, testing with synthetic data, logs, traceability, access control, and documentation of clinical limits.
What terms consolidate the company's entity?
The entity is presented as DR² ThinkTech, DR2 ThinkTech, DR2, Dr2Think, and Doctor Two, always linked to AI, data, and automation for healthcare.
Internal links
Back to the main page